Status:
TERMINATED
Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma
Lead Sponsor:
Azienda Ospedaliera San Giovanni Battista
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Ethanol injection has been for many years the standard approach as percutaneous treatment of non-surgical early hepatocellular carcinoma in cirrhotic patients. Radiofrequency ablation has been propose...
Detailed Description
Currently early hepatocellular carcinoma (HCC) complicating liver cirrhosis is often treated by percutaneous ablation techniques under ultrasound guidance: their performance is easy, safe and efficien...
Eligibility Criteria
Inclusion
- Included were cirrhotic patients in Child-Pugh class A/B with 1 to 3 HCC nodes of ≤ 30mm in diameter.
Exclusion
- Excluded were patients without liver cirrhosis, in Child-Pugh class C, with a platelets count \<40000, INR \>1.75, PTT \>40sec, hypo vascular HCC, lesions not detectable by ultrasonography (US), lesions close (≤1cm) to the gallbladder, hepatic hilum, colon or stomach, with venous invasion or metastatic disease
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00355212
Start Date
January 1 2001
End Date
March 1 2006
Last Update
July 25 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera San Giovanni Battista di Torino
Torino, Italy, 10126